203 354

Cited 0 times in

간세포암의 정위적 체부 방사선 치료에서 적합한 치료 방침 선택에 관한 연구

DC FieldValueLanguage
dc.contributor.author성진실-
dc.contributor.author최서희-
dc.contributor.author우중열-
dc.contributor.author최서희-
dc.date.accessioned2017-11-02T08:34:45Z-
dc.date.available2017-11-02T08:34:45Z-
dc.date.issued2017-
dc.identifier.issn2288-8128-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/154634-
dc.description.abstractBackground/Aims: As the optimal stereotactic body radiation therapy (SBRT) modality for hepatocellular carcinoma (HCC) has not been confirmed, we aimed herein to provide a practical guideline by our retrospective review. Methods: Thirty-nine patients with primary HCC who underwent liver SBRT via 3 modalities (helical tomotherapy [HT]: 22, volumetric modulated arc therapy [VMAT]: 13, Cyberknife: 4) at our institution between July 2014 and July 2015 were included. Modalities were compared with regard to dose conformity index (CI), homogeneity index (HI), clinical results, and patient compliance. Results: VMAT SBRT had favorable conformity (CI: 0.7±0.2), homogeneity (HI: 1.1±0.0), and shortest treatment time (100.2±26.1 seconds). HT SBRT yielded good dosimetric outcomes, especially in conformity (CI: 1.0±0.2). Although the Cyberknife SBRT synchrony system allowed real-time tumor targeting, the treatment time was longest (3,015.0±447.3 seconds), invasive pre-treatment procedures were required, and the HI (1.3±0.0) was lowest. Conclusions: All 3 modalities yielded competent dosimetric planning parameters. VMAT SBRT was most appropriate for tumors with residual lipiodol or patients with poor conditions. HT SBRT is available for multiple or irregular targets. Cyberknife SBRT is recommended for carefully selected patients and tumors indicated for sono-guided fiducial insertion. (J Liver Cancer 2017;17:45-53)-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageKorean-
dc.publisher대한간암학회-
dc.relation.isPartOfJournal of Liver Cancer (대한간암학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title간세포암의 정위적 체부 방사선 치료에서 적합한 치료 방침 선택에 관한 연구-
dc.title.alternativeSelection of Proper Modality in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-
dc.typeArticle-
dc.publisher.locationKorea (South)-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Radiation Oncology-
dc.contributor.googleauthor최서희-
dc.contributor.googleauthor우중렬-
dc.contributor.googleauthor성진실-
dc.identifier.doi10.17998/jlc.17.1.45-
dc.contributor.localIdA04867-
dc.contributor.localIdA04981-
dc.contributor.localIdA01956-
dc.relation.journalcodeJ03078-
dc.relation.journalsince2014-
dc.relation.journalbefore~2013 Journal of the Korean Liver Cancer Study Group (대한간암연구학회지)-
dc.subject.keywordRadiotherapy-
dc.subject.keywordHepatocellular carcinoma-
dc.subject.keywordVolumetric-Modulated Arc Therapy-
dc.subject.keywordHelical tomotherapy-
dc.contributor.alternativeNameSeong, Jin Sil-
dc.contributor.alternativeNameChoi, Seo Hee-
dc.contributor.alternativeNameWoo, Joong Yeol-
dc.contributor.affiliatedAuthorChoi, Seo Hee-
dc.contributor.affiliatedAuthorWoo, Joong Yeol-
dc.contributor.affiliatedAuthorSeong, Jin Sil-
dc.citation.titleJournal of Liver Cancer (대한간암학회지)-
dc.citation.volume17-
dc.citation.number1-
dc.citation.startPage45-
dc.citation.endPage53-
dc.identifier.bibliographicCitationJournal of Liver Cancer (대한간암학회지), Vol.17(1) : 45-53, 2017-
dc.date.modified2017-11-01-
dc.identifier.rimsid43692-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.